IAV NA

Loading...

Anti-IAV NA Products

+ Filter
Loading...
View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Background

Influenza A viruses cause considerable morbidity and mortality annually, posing threats to public health worldwide. Monoclonal antibodies represent a viable approach for the treatment of influenza. Antibodies targeting hemagglutinin (HA) and neuraminidase (NA), the two important surface glycoproteins of influenza virus, can disrupt viral entry into host cells and block viral egress or prevent virus from budding, respectively. Earlier work defined the structure of NA and NA-fragment antigen-binding (Fab) complexes and demonstrated the protective effects of immune responses to NA.
Go to compare

Go to compare